Company page

Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. (Ticker: SRPT) is a public company based in the United States, specializing in the development of innovative therapies for rare genetic diseases. With a market capitalization of approximately $1.66 billion, Sarepta focuses on advancing treatments for conditions such as Duchenne muscular dystrophy. The company is committed to improving the lives of patients through its research and development efforts.